Herbies Headshop

sensi seeds skunk

Medical Cannabis News

GW Pharmaceuticals Announces Successful Closing of Mutual Recognition Procedure for Sativex in France

London, UK; 21 October 2013: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced the successful closing of the European Mutual Recognition Procedure (MRP) in France for Sativex® oromucosal spray in the treatment of spasticity due to Multiple Sclerosis (MS) and a resulting recommendation for approval by the French authorities.

FDA Approves Investigational Trials Assessing Cannabidiol For Pediatric Epilepsy

Washington, DC: The US Food and Drug Administration has approved two clinical trials to assess the efficacy of cannabidiol (CBD), a nonpsychoactive plant cannabinoid, in the treatment of intractable pediatric epilepsy. The two approved trials will take place at New York Medical School and at the University of California at San Francisco, according to an online report in the journal O'Shaughnessy's. The cannabidiol formulations in the trials will be provided by British biotechnology firm GW Pharmaceuticals, which produces organic cannabinoid extract medicines, including Sativex.

Study shows non-hallucinogenic cannabinoids are effective anti-cancer drugs

New research has shown that the non-hallucinogenic components of cannabis could act as effective anti-cancer agents.

The anti-cancer properties of tetrahydrocannabinol (THC), the primary hallucinogenic component of cannabis, has been recognised for many years, but research into similar cannabis-derived compounds, known as cannabinoids, has been limited.

The study was carried out by a team at St George’s, University of London. It has been published in the journal Anticancer Research.

Study Finds Cannabis Protects Against Sepsis

According to a study published earlier this year by the National Institute of Health, activation of the body’s cannabinoid receptors – something which cannabis does naturally – can protect against sepsis, a serious inflammatory illness which is due to a severe reaction to bacteria or germs, which often proves fatal.

During the study, which used mice subjects, researchers found that activation of the cannabinoid receptor 2 (CB2R) can “significantly extend the survival rate and decrease serum proinflammatory cytokines” in those with sepsis.

Cannabis May Treat Celiac Disease, According to Recent Government-Published Study

A National Institute of Health study published earlier this year found that cannabis may treat celiac disease by activating the body’s natural cannabinoid receptors. Celiac disease is an autoimmune disorder of the small intestine which some people are genetically predisposed to.

The study, which was conducted by researchers at the Department of Biomedical Sciences at the University of Teramo in Italy, aimed to “investigate the expression of CBR [cannabinoid receptors] at transcriptional and translational levels in the duodenal mucosa of untreated celiac patients, celiac patients on a gluten-free diet for at least 12 months and control subjects. Also biopsies from treated celiac patients cultured ex vivo with peptic-tryptic digest of gliadin were investigated.”

Study Finds Cannabis-Infused Microparticles Effectively Inhibit Tumor Growth

A study published recently by the journal PLoS One, as well as the National Institute of Health, has found that cannabis-infused microparticles can be an effective anticancer agent.

For the study, researchers “analyzed CBD- and THC-loaded poly-ε-caprolactone microparticles as an alternative delivery system for long-term cannabinoid administration in a murine xenograft model of glioma [a type of tumor]”

Canada Rolls Out a ‘$1 Billion’ Privatized Medical Marijuana Industry

Marijuana was Canada’s newest mail-order product Tuesday, the inaugural day of a controlled medical marijuana industry that is expected to grow to more than $1 billion dollars within 10 years. But even as the new system privatizes distribution, critics fear regulation under the conservative-led government will make it harder for patients to get access to the drug.

In Canada, medical marijuana has been legal but highly regulated for more than a decade. Patients with doctor approval could grow or have someone else grow small quantities or request limited amounts from Health Canada, the national healthcare department.

New data reinforces the efficacy and safety profile of cannabis in Multiple Sclerosis Spasticity

London, UK; 2 October 2013: GW Pharmaceuticals plc (AIM: GWP, Nasdaq: GWPH, "GW") announced that data from new MS spasticity studies (clinical trial data, observational study data and registries data collection) is being presented today at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Copenhagen, Denmark. The following press release was issued today by GW’s commercial partner, Almirall S.A., regarding the data presentation:

Copenhagen, Denmark, 2nd October 2013: Almirall S.A. (ALM) today announces the latest evidence with Sativex® (THC:CBD spray) from new MS spasticity studies (clinical trial data, observational study data and registries data collection). These data, presented today at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Copenhagen, Denmark, show that Sativex® effectiveness is maintained long term with no additional safety concerns identified in clinical practice.

US Supreme Court Rejects Marijuana Reclassification Appeal

The US Supreme Court Monday declined to hear an appeal from medical marijuana advocacy groups who had challenged the DEA's decision to maintain marijuana's status as a Schedule I drug under the Controlled Substances Act, the category reserved for the most dangerous substances.

The court denied in summary order a petition for a writ of certiorari from the groups, led by Americans for Safe Access, which had sought Supreme Court review of a DC Circuit Court of Appeals decision upholding the DEA's ruling that a change in marijuana's classification required the Food and Drug Administration's recognition of acceptable medical uses for the drugs.

Cancer patients denied cannabis, made to do chemo instead

Several studies by top medical researchers, including from Harvard University, have concluded that the drug cannabis sativa (aka marijuana) provides more effective treatment for different types cancer than chemotherapy, without the severe side effects associated with the exposure to radiation.

But patients who seek this alternative form of therapy in Malta are denied access to cannabis-based products, on the pretext that the plant from which they are derived is listed on the Dangerous Drugs Ordinance of 1971.

One local patient, who asked not to be named, contacted MaltaToday to recount his own experiences after reading an article about the medical properties of marijuana in our Wednesday edition.

cannabis seeds

autoflowering cannabis seeds

cannabis seeds

Want to grow your own?

If you are looking for good quality seed to grow your own medicine at home, then check out those guys from Royal Queen Seeds.  With more than 2 decades of experience they ship their medical cannabis seeds world wide and guarantee top quality for the best price. Award winners shipped stealth!  What more do you need?